The U.S. sex reassignment surgery market size was valued at USD 267.0 million in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 14.4% from 2020 to 2027. The rising incidences of gender dysphoria and the increasing number of people deciding for gender confirmation surgeries are expected to boost market growth over the forecast period. Sex reassignment surgeries are performed by a multispecialty staff that usually involves board-certified or licensed plastic surgeons. The objective of surgical procedure is to give transgender individuals the functional abilities and physical appearance of the gender they align their emotional and psychological identity with. It includes procedures such as facial feminization surgery, transfeminine bottom surgery, transfeminine top surgery, transmasculine top surgery, facial masculinization surgery, and transmasculine bottom surgery.
According to the 2019 Plastic Surgery Statistics by the American Society of Plastic Surgeons, around 11,000 gender confirmation or sex reassignment surgeries were performed in the U.S., which was around 10% to 15% higher than the previous year. The increasing number of sex reassignment surgeries in the U.S. will propel the growth of the market during the forecast period.
Transgender people going through sex reassignment or gender confirmation surgery are described as transsexual. Usually, the surgery is done on people with gender dysphoria, and patients experiencing gender dysphoria usually go through unhappiness, anxiety, and depression of not being recognized or accepted by society and having sexual characteristics that they are not comfortable with. Increasing the number of sex reassignment surgeries is among the major factors driving the sex reassignment surgery market.
Improving reimbursement scenario is also anticipated to positively impact the market growth over the forecast period. Insurance providers like Aetna and Unicare provide insurance for necessary surgical procedures, such as salpingo-oophorectomy, hysterectomy, orchiectomy, or ovariectomy.
Based on gender transition, the market is segmented into male to female and female to male. The female to male segment dominated the market in 2019 and accounted for 55.2% share of the overall revenue. This is attributed to the increasing number of women opting for sex-change surgeries.
Even though most people in the female to male category opt for other procedures, such as chest contouring, bilateral mastectomy (breast removal), and hysterectomy, the number of people opting for sex reassignment surgery is increasing. This is anticipated to maintain the lead of the segment over the forecast period.
The ongoing COVID-19 pandemic has forced people worldwide to stay indoors or in self-isolation. This has led to a decrease in the number of sex reassignment surgeries. Everyone is going through an exceptionally stressful time all around the globe. As with many plastic surgeons, most of the surgeries are on hold as they are on the list of the so-called "elective" surgical procedures or surgeries, which include gender-affirming surgeries for patients suffering from gender dysphoria.
Sex reassignment surgeries (SRS) or gender-affirming surgeries are life-altering surgical practices that give transgender individuals the functional abilities and physical appearance of the sexual characteristics of the gender they know themselves to be. The growing acceptance of the transgender population and the rising number of reconstructive surgeries are expected to increase the demand for sex reassignment surgeries during the forecast period. Some prominent players in the U.S. sex reassignment surgery market include:
Mount Sinai
Transgender Surgery Institute of Southern California
Cedars Sinai
Moein Surgical Arts
Boston Medical Center
Cleveland Clinic
CNY Cosmetic & Reconstructive Surgery
Plastic Surgery Group Rochester
Report Attribute |
Details |
Market size value in 2020 |
USD 304.8 million |
Revenue forecast in 2027 |
USD 781.8 million |
Growth Rate |
CAGR of 14.4% from 2020 to 2027 |
Base year for estimation |
2019 |
Historical data |
2016 - 2018 |
Forecast period |
2020 - 2027 |
Quantitative units |
Revenue in USD million and CAGR from 2020 to 2027 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Gender transition |
Country scope |
U.S. |
Key companies profiled |
Mount Sinai; Transgender Surgery Institute of Southern California; Cedars Sinai; Moein Surgical Arts; Boston Medical Center; Cleveland Clinic; CNY Cosmetic & Reconstructive Surgery; Plastic Surgery Group Rochester |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts the revenue growth at the country level and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2016 to 2027. For this study, Grand View Research has segmented the U.S. sex reassignment surgery market report based on gender transition:
Gender Transition Outlook (Revenue, USD Million, 2016 - 2027)
Male to Female
Female to Male
b. Some of the key players operating in the U.S. sex reassignment surgery market are Mount Sinai, Transgender Surgery Institute of Southern California, Cedars Sinai, Moein Surgical Arts, Boston medical center, Cleveland clinic, CNY Cosmetic & Reconstructive Surgery, and Plastic Surgery Group Rochester.
b. The increasing incidences of gender dysphoria and the increasing number of people deciding for gender confirmation surgeries are expected to boost U.S. sex reassignment surgery market growth over the forecast period.
b. The U.S. sex reassignment surgery market size was estimated at USD 267.0 million in 2019 and is expected to reach USD 304.8 million in 2020.
b. The U.S. sex reassignment surgery market is expected to grow at a compound annual growth rate of 14.4% from 2020 to 2027 to reach USD 781.8 million by 2027.
b. Female to Male segment dominated the U.S. sex reassignment surgery market in 2019 due to the increasing number of women opting for sex-change surgeries.
GET A FREE SAMPLE
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
NEED A CUSTOM REPORT?
We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.
Contact us now to get our best pricing.
We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure.
"The quality of research they have done for us has been excellent."
We value your investment and offer free customization with every report to fulfil your exact research needs.